Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors
Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane
Kaohsiung Medical University Chung-Ho Memorial Hospital
500 participants
Apr 26, 2022
INTERVENTIONAL
Conditions
Summary
This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma. The study will enroll approximately 500 volunteers to compare the progression-free or overall survival in patients undergoing elective partial hepatectomy for primary liver tumors between propofol and sevoflurane for the maintenance of anesthesia.
Eligibility
Inclusion Criteria3
- Twenty to eighty-year-old.
- ASA class I-III.
- Patients undergoing partial hepatectomy for hepatocellular carcinoma under general anesthesia.
Exclusion Criteria12
- Severe mental disorder
- Pregnant or lactating women
- Morbidly obese
- Allergy to any of the drugs used in this study
- Recurrent tumor or repeat surgery
- Biopsy cases
- Incomplete data collection before the surgery
- Palliative treatment after surgery
- simultaneous treatment of other malignancies
- Combined propofol and inhalation anesthesia or other anesthetics, such as ketamine or dexmedetomidine
- Diagnosed as benign liver tumor
- Emergency surgery
Interventions
total intravenous anesthesia with propofol for the partial hepatectomy of hepatocellular carcinoma.
The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3 MAC).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05331911